Spironolactone Tablet
Product Images NDC 65162-511

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 65162-511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10 (Spironolactone Tablets Usp Us 1)

FDA Label Image

10 (Spironolactone Tablets Usp Us 2)

10 (Spironolactone Tablets Usp Us 2)
This text seems to show some statistical data related to two groups, one treated with Spironolactone and the other with Piaceto. The sample size (n) for each group is provided (822 for Spironolactone and 841 for Piaceto) and there is a significance value (Log-rank p) of less than 0.001, suggesting a statistically significant difference between the two groups. The last line contains some numbers that are not clear in their meaning or context.*
FDA Label Image

10 (Spironolactone Tablets Usp Us 3)

10 (Spironolactone Tablets Usp Us 3)
This appears to be a table with headers "Subgroup", "Disberns", "SurConmiing (ap/2L)", "G Clumses (Lmiat T)", "Porssius (amsi)", "Level", "HR" and "95% CI". However, without additional context, it is not possible to determine the meaning or significance of the data in the table.*
FDA Label Image

1 (Spironolactone Tablets Usp Us 4)

1 (Spironolactone Tablets Usp Us 4)
This is a medication label for spironolactone tablets. Each tablet contains 25mg of Spironolactone, USP. The label indicates the usual adult dosage can be found in attached literature. It is recommended to store the tablets at a temperature of 20° to 25°C (68° 1o 77°F) and to dispense them in a tight, light-resistant container. This medication is only available with a prescription and is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ. Rev. 03-2018-01.*
FDA Label Image

2 (Spironolactone Tablets Usp Us 5)

2 (Spironolactone Tablets Usp Us 5)
This is a description of spironolactone tablets, indicated for adults, with each tablet containing 50 mg of Spironolactone. It includes instructions to store the tablets in a tight, light-resistant container within at a controlled room temperature of 20° to 25°C (68° to 77°F) and dosage information can be found in attached literature. These tablets are distributed by Amneal Pharmaceuticals LLC located in Bridgewater, NJ 08807.*
FDA Label Image

3 (Spironolactone Tablets Usp Us 6)

3 (Spironolactone Tablets Usp Us 6)
This text is a description of a medication, specifically a tablet containing Spironolactone, USP. The usual adult dosage is referenced, but additional information is available in attached literature. The medication should be dispensed in a light-resistant container. The tablet is produced by Amneal Pharmaceuticals LLC and each package contains 30 tablets. The text also includes a revision date and a lot and expiration date code.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.